An Essential Parameters of Genetic Evaluation Regarding Gastric Cancer Include Genetic Testing Approach, Multiple Panel Testing Applications and Cascade Genetic Testing
Abstract
Hereditary gastric cancer syndromes may account for 15% to 20% of gastric cancer cases. It is advised that healthcare professionals obtain a thorough, three-generation family history and, if necessary, do genetic testing if they believe a patient has a hereditary stomach cancer syndrome. Estimating the risk of stomach cancer requires a thorough personal and family history.
References
Uson, P. L. S., Kunze, K. L., Golafshar, M. A., et al. (2022). Germline cancer testing in unselected patients with gastric and esophageal cancers: A multi-center prospective study. Digestive Diseases and Sciences, 67(11), 5107–5115. https://doi.org/10.1007/s10620-021-07356-0
Ku, G. Y., Kemel, Y., Maron, S. B., et al. (2021). Prevalence of germline alterations on targeted tumor-normal sequencing of esophagogastric cancer. JAMA Network Open, 4(7), e2114753. https://doi.org/10.1001/jamanetworkopen.2021.14753
Oliveira, C., Pinheiro, H., Figueiredo, J., et al. (2015). Familial gastric cancer: Genetic susceptibility, pathology, and implications for management. The Lancet Oncology, 16(2), e60–e70. https://doi.org/10.1016/S1470-2045(14)71016-2
Frebourg, T., Oliveira, C., Hochain, P., et al. (2006). Cleft lip/palate and CDH1 (E-cadherin) mutations in families with hereditary diffuse gastric cancer. Journal of Medical Genetics, 43(2), 138–142. https://doi.org/10.1136/jmg.2005.031385
Qureshi, N., Wilson, B., Santaguida, P., et al. (2007). Collection and use of cancer family history in primary care (Evidence Report/Technology Assessment No. 159). Agency for Healthcare Research and Quality.
Mitchell, R. J., Brewster, D., Campbell, H., et al. (2004). Accuracy of reporting of family history of colorectal cancer. Gut, 53(2), 291–295. https://doi.org/10.1136/gut.2003.017079
Douglas, F. S., O'Dair, L. C., Robinson, M., et al. (1999). The accuracy of diagnoses as reported in families with cancer: A retrospective study. Journal of Medical Genetics, 36(4), 309–312. https://doi.org/10.1136/jmg.36.4.309
Ozanne, E. M., O'Connell, A., Bouzan, C., et al. (2012). Bias in the reporting of family history: Implications for clinical care. Journal of Genetic Counseling, 21(4), 547–556. https://doi.org/10.1007/s10897-011-9460-6
Mai, P. L., Garceau, A. O., Graubard, B. I., et al. (2011). Confirmation of family cancer history reported in a population-based survey. Journal of the National Cancer Institute, 103(10), 788–797. https://doi.org/10.1093/jnci/djr114
Rashid, A., & Jagger, C. (1996). Patients' knowledge of anatomical location of major organs within the human body: A comparison between Asians and non-Asians. Family Practice, 13(5), 450–454. https://doi.org/10.1093/fampra/13.5.450
Fiederling, J., Shams, A. Z., & Haug, U. (2016). Validity of self-reported family history of cancer: A systematic literature review on selected cancers. International Journal of Cancer, 139(7), 1449–1460. https://doi.org/10.1002/ijc.30205
Blair, V. R., McLeod, M., Carneiro, F., et al. (2020). Hereditary diffuse gastric cancer: Updated clinical practice guidelines. The Lancet Oncology, 21(8), e386–e397. https://doi.org/10.1016/S1470-2045(20)30219-9
Colvin, H., Yamamoto, K., Wada, N., et al. (2015). Hereditary gastric cancer syndromes. Surgical Oncology Clinics of North America, 24(4), 765–777. https://doi.org/10.1016/j.soc.2015.06.004
Xicola, R. M., Li, S., Rodriguez, N., et al. (2019). Clinical features and cancer risk in families with pathogenic CDH1 variants irrespective of clinical criteria. Journal of Medical Genetics, 56(12), 838–843. https://doi.org/10.1136/jmedgenet-2019-106164
National Cancer Institute. (2025). SEER cancer stat facts: Stomach cancer. U.S. Department of Health and Human Services. https://seer.cancer.gov/statfacts/html/stomach.html
Hampel, H., Bennett, R. L., Buchanan, A., et al. (2015). A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: Referral indications for cancer predisposition assessment. Genetics in Medicine, 17(1), 70–87. https://doi.org/10.1038/gim.2014.147
Domchek, S. M., Bradbury, A., Garber, J. E., et al. (2013). Multiplex genetic testing for cancer susceptibility: Out on the high wire without a net? Journal of Clinical Oncology, 31(10), 1267–1270. https://doi.org/10.1200/JCO.2012.46.9403
Pharoah, P. D. P., Guilford, P., Caldas, C., et al. (2001). Incidence of gastric cancer and breast cancer in CDH1 (E-cadherin) mutation carriers from hereditary diffuse gastric cancer families. Gastroenterology, 121(6), 1348–1353. https://doi.org/10.1053/gast.2001.29611
Corso, G., Intra, M., Trentin, C., et al. (2016). CDH1 germline mutations and hereditary lobular breast cancer. Familial Cancer, 15(2), 215–219. https://doi.org/10.1007/s10689-016-9878-2
van der Kaaij, R. T., van Kessel, J. P., van Dieren, J. M., et al. (2018). Outcomes after prophylactic gastrectomy for hereditary diffuse gastric cancer. British Journal of Surgery, 105(2), e176–e182. https://doi.org/10.1002/bjs.10678
Lowstuter, K., Espenschied, C. R., Sturgeon, D., et al. (2017). Unexpected CDH1 mutations identified on multigene panels pose clinical management challenges. JCO Precision Oncology, 1, 1–12. https://doi.org/10.1200/PO.16.00039
Katona, B. W., Clark, D. F., & Domchek, S. M. (2020). CDH1 on multigene panel testing: Look before you leap. Journal of the National Cancer Institute, 112(4), 330–334. https://doi.org/10.1093/jnci/djz186
National Comprehensive Cancer Network. (2023). NCCN clinical practice guidelines in oncology: Genetic/familial high-risk assessment: Breast, ovarian, and pancreatic (Version 3.2023). National Comprehensive Cancer Network. https://www.nccn.org/professionals/physician_gls/
Hampel, H. (2016). Genetic counseling and cascade genetic testing in Lynch syndrome. Familial Cancer, 15(3), 423–427. https://doi.org/10.1007/s10689-016-9888-0
Refbacks
- There are currently no refbacks.